May 3, medical net 

 

There is no return to the low price of a regular film 

 

Whether it's a mass purchase or a bid for a single auction, the average film now seems to be locked in a downward spiral. The interests of all the people on the chain was extremely profound negative impact: manufacturer losses, channel reckon, users pay for the medical risk, patients do not have access to reliable medical resources. 

 

In August 2015, hubei province opened the mouth of the low-priced batch procurement, and 28 regular films were priced at 215,000. The industry was in the process of doing so, arguing that it was an irrational market operation, probably for the sake of stirring up the industry. 

 

But by 2016, the price of purchasing items in bulk in China has stabilized at low prices. In chengdu, for example, 64 batch procurement projects were eventually purchased at 35.67 million yuan. Centralized procurement prices in other parts of the country are also fluctuating between 30 and 45, 000, and concentrated purchasing prices tend to be rational. 

 

In 2017, the hunan province logo also made the industry a big hit, with the famous 50 common film projects. This project runs smooth, the beginning is factory direct price is 205000 / sets of won the bid, then the river's lake legend second manufacturers through the operation, with 226980 / Taiwan, and rumors project eventually be waste. The project, regardless of the final outcome, shows that bids for all participants were very low, with only 288, 000 for the highest bid. 

 

In the case of single purchases, there is a general trend: the more advanced the economy, the more transparent the information, the closer it is to the coast, the lower the purchase price. Currently single purchase price than the bulk purchase price is higher, but overall, removal of guangxi, xinjiang, GanQingNing special areas, such as the purchase price is in commonly between 25-750000 / sets, and the vast majority of 25-450000 / ratio. 

 

Since 2015, it has been possible to find out that the low-price purchase of a common film is a no-go, whether through a centralized purchase or a single purchase. 

 

Second, there will be low prices in the near future 

 

First, the emergence of new technology products in the industry, the clinical shortcomings of general film production DR, is the root cause of the great escape. 

 

Low price competition, on the surface is the competition of each manufacturer model, in fact is the competition that involves core technology, core product. There are now more than 150 manufacturers, many of whom were reported to have fallen in the real estate sector during the 2013-14 period. Many of them enter the industry, and it is difficult for them to develop, produce, and serve their own development in a short period of time. Under the influence of the development trend of the short and fast modern enterprise, many manufacturers have chosen the road of assembling parts, which is the "shanzhai mode" that we are familiar with. Because of the accumulation of capital, the competition threshold is too low, so the market is good. So, now the market is cold, what to do? It can only be the manufacturer's bottom, seize the time assets to cash in, otherwise, miss the time, the asset becomes the burden. So low price competition finds its roots: the assembled product, when the industry contracts, it takes time to cash in and out. And the more the industry contracts, the more time it takes for factories to dump their goods. 

 

Second, the marketing model distorts and speeds up the normal production of DR. 

 

In the early stage of homogenization competition, the price war, in the existing profit space, the lower bottom line repeatedly, the enterprise more and more approaches net profit to zero; , in the middle of the war is cost control, the price war in the early days, the industry average profit has been unable to support enterprise development, can cut back on spending, such as research and development, marketing support department downsizing or cut directly, and gradually extended to the service team, marketing team, and even becomes a geek enterprises: only the production and marketing. Homogeneity of late, the expense of the marketing system is gradually shrinking, the current average shooting DR manufacturer to a recruit: the existing business personnel directly to the development of their own dealers, marketing costs further compression, this recruit the jugular, push the enterprise directly into madness to jilt liquid phase. 

 

Third, buyers now seem to be being held down by low prices and are afraid to buy high-value products. 

 

Now the purchase is popular with the market, the buyer always wants to see the purchase price of the old wangjia home next door is how much, do a reference. In the overall environment at a lower price, the owner also helpless, whether or not the product is able to meet their own needs, budget is only so much, when the superior department for approval, also want to look at the whole bidding price. Under anticorruption pressure, no one is willing to break the rules, even if the product is not required. Users were kidnapped at low prices, and they were helpless. 

 

So, the manufacturer jilt, the salesman change the channel businessman, the user is kidnapped by the low price, in the face of fresh demand, the recent crazy low price also will be frequency now. 

 

3, what is the future of the generic film DR? 

 

To return to the rational path of enterprise development, enterprises need to have a core competitiveness. Enterprise only created from already have, others are difficult to imitate advantages, in the short term and the advantage of the competitiveness of the user to create value ", to obtain long-term survival capital. In particular, it is to have the hard product, the excellent brand, the perfect channel etc. So, if the manufacturer wants to develop, he will find a new technological breakthrough. It's hard to do that if you're just in the existing product market. 

 

There are several options for the current market for the common film, DR. 

 

First, we should return to the main road of self-development. This, for many companies, may feel powerlessness, because development means to spend a lot of time and money, to be a fundamental subversion of the existing competition pattern, and may increase the risk of the enterprise. But in the long run, self-development is not far away, and self-development will at least have the advantage of being able to compete in the future of technology. For companies with abundant resources, they should return to the path of self-development as soon as possible. 

 

Second, focus on smaller segments. The healthcare industry is growing rapidly, and there is a growing demand for differentiated customers, and there are huge opportunities in any segment. In the past, there was only one old X-ray machine, and in the latter part of the day, the bed side machine, the car engine, the mobile machine. For now, there are a number of areas that can be further subdivided, for example: is it possible to introduce targeted products in different departments? Can there be more professional product opportunities for animal testing? Are there any opportunities for first aid products? And so on. 

 

In fact, the question of long-term development needs to be considered in both general and other medical fields. At present, China is not lack of innovation, especially on the new model of innovation, we can say is a leading global, products, technology, but do need more spirit. A good craftsman, who needs to experience a lot of frustration, repeatedly improves his own power, and makes a masterpiece. To be a good and growing enterprise, we must also focus, focus and focus.